Application no. and date | 15750139.6 (espacenet) (Federated) (European Patent Register), 20150806 | Patent/reg. no. and date | DK/EP 3177642, 20211124 | Publication date | 20170614 | Priority no. and date | US 201462034409 P, 20140807 | EP pub. no. and date |
EP 3177642 20170614 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | BT/GP/165810 | Inventor | TRAUGER, John, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, MA 02139, US, VOZNESENSKY, Andrei Igorevich, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, MA 02139, US, CEBE, Regis,
Basel, 4002, CH, SPLAWSKI, Igor,
Winchester, MA 01890, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 3/00 (2006.01) , C07K 16/22 (2006.01) | Title | ANGIOPOIETIN-LIGNENDE 4-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | IB2015055986 | Int. publication no. | WO2016020880 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|